Search

Search Constraints

You searched for: Author/Creator Elli, Elena Maria

Search Results

1. Association of Platelet Thromboxane Inhibition by Low‐Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia. Issue 4 (20th November 2021)

2. Biosimilar erythropoiesis‐stimulating agents are an effective and safe option for the management of myelofibrosis‐related anemia. (16th December 2022)

3. Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients. Issue 7 (2nd June 2016)

4. Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX‐IOL study. (8th February 2022)

5. Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID‐19. Issue 12 (27th September 2022)

6. Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia. Issue 6 (6th December 2020)

7. Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approach. Issue 4 (22nd August 2019)

8. Large-scale analysis of SARS-CoV-2 synonymous mutations reveals the adaptation to the human codon usage during the virus evolution. Issue 1 (24th March 2022)

9. Management of polycythemia vera: A survey of treatment patterns in Italy. (10th November 2022)

10. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study. Issue 10373 (28th January 2023)